Arcadia Biosciences (RKDA) Names Stan Jacot as CEO
Jacot holds an impressive track record of implementing transformational business strategies and profitably driving growth, most recently at
"There's a clear opportunity to grow Arcadia's brands while improving the lives of consumers through our portfolio of better-for-you products," said Jacot. "Now is an exciting time to join the organization, as we prepare for the launch of GoodWheat™ pasta. The food we eat plays a significant role in our collective health, and I look forward to positively impacting the wellbeing of countless consumers through this revolutionary new line of pastas from the next generation of wheat – our GoodWheat."
Jacot was selected as CEO by Arcadia's board of directors after a nationwide search. The role was previously held by
"Stan has built an impressive career developing organizations and strategies to drive aggressive growth for existing and emerging better-for-you consumer brands," said Comcowich. "As we continue to transform Arcadia, we are thrilled to have him on board to lead the organization through its next phase of growth."
In connection with the appointment, Arcadia granted Jacot an inducement stock option to purchase a total of 316,108 shares of its common stock. The stock option was granted outside of Arcadia's 2015 Omnibus Equity Incentive Plan (but under the same terms) and was material to Jacot's acceptance of employment with Arcadia. The inducement grant was made and approved in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option was issued upon his commencement of employment (the grant date), and has an exercise price per share of
With origins as a trailblazing developer of science-based approaches to enhancing the quality and nutritional value of crops and food ingredients,
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the launch of GoodWheat pasta and the growth of the Company's brands. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to, the risks set forth in Arcadia's Annual Report on Form 10-K for the year ended
View original content to download multimedia:https://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-names-stan-jacot-as-ceo-301474163.html
Press Contacts - Marie Espinel or Hannah Arnold, The LAKPR Group, email@example.com or firstname.lastname@example.org; Investor Contact - Pam Haley, Chief Financial Officer, email@example.com